Late developmental regulation in Chlamydia
衣原体的晚期发育调控
基本信息
- 批准号:9978694
- 负责人:
- 金额:$ 44.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAntibioticsBacteriaBindingCase StudyCellsCenters for Disease Control and Prevention (U.S.)ChlamydiaChlamydia InfectionsCommunicable DiseasesConfocal MicroscopyCytoplasmDNA-Directed RNA PolymeraseDevelopmentDimerizationDisease NotificationDisulfidesEnzyme TestsEscherichia coliEventGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGlucoseGoalsHeterogeneityHumanIn VitroIndividualInfectionInfectious AgentInterruptionLate Gene TranscriptionsLeadMembraneMolecular TargetOxidation-ReductionOxidesOxidoreductasePathway interactionsPatternPeptide HydrolasesPhosphoenolpyruvatePhosphoric Monoester HydrolasesPredispositionProductionProteolysisPublic HealthQuantitative Reverse Transcriptase PCRRegulationRegulatory PathwayReportingRepressionRoleSexually Transmitted DiseasesSigma FactorSignal PathwaySourceSupplementationTestingTimeTranscription RepressorTranscriptional Regulationchromatin immunoprecipitationderepressiondimerdisulfide bondenolasegenital infectionin vitro Assayin vivomonomernovelnovel therapeuticsprematurepreventresponsetherapeutic targettransmission process
项目摘要
Project Summary/Abstract
Chlamydia is one of the most important infectious agents from a public health
perspective. In 2014 more than 1.4 million cases of chlamydial infections were reported
to the CDC making it the most commonly reported infectious disease in the U.S.
Chlamydia causes an unusual intracellular infection in which there are two specialized
forms of the bacterium within an infected cell. The reticulate body (RB) is an intracellular
form that replicates via multiple rounds of binary fission. Then at a late stage in the
intracellular infection, each RB asynchronously converts into an elementary body (EB),
which is the infectious form that transmits the infection to a new cell. We propose to
study how this late developmental change from an RB to an EB is regulated by focusing
on a small group of chlamydial genes that are upregulated at late times in the infection.
We have evidence that these late genes are negatively regulated to prevent their
premature expression. In Aim 1, we will study a transcriptional regulator called EUO to
understand how its repression of late genes is relieved at late times to allow these genes
to be expressed. We hypothesize that EUO is converted in a redox-dependent manner
from a dimer into a monomer that is then degraded by proteolysis. In Aim 2, we will
study another regulator called RsbW, which we propose is part of a signaling pathway
that controls the transcription of a subset of late genes by σ28 RNA polymerase in
response to glucose availability. Aim 3 will use confocal microscopy to examine these
mechanisms of late gene regulation in individual RBs and EBs within a single infected
cell. We will investigate whether the regulators of late gene expression also control RB-
to-EB conversion and why this critical conversion step occurs asynchronously. These
studies have the potential to lead to novel therapeutic strategies for treating chlamydial
infections by interrupting this critical conversion step and preventing the production of
infectious bacteria.
项目概要/摘要
衣原体是公共卫生领域最重要的传染源之一
看法。 2014年报告了超过140万例衣原体感染病例
CDC 使其成为美国最常报告的传染病
衣原体引起一种不寻常的细胞内感染,其中有两种专门的感染
受感染细胞内细菌的形式。网状体(RB)是细胞内的
通过多轮二元裂变复制的形式。然后在后期阶段
细胞内感染,每个RB异步转化为基本体(EB),
这是将感染传播到新细胞的感染形式。我们建议
研究这种从 RB 到 EB 的晚期发育变化是如何通过聚焦来调节的
一小群衣原体基因在感染后期上调。
我们有证据表明这些晚期基因受到负调控以防止它们的发生
过早表达。在目标 1 中,我们将研究一种名为 EUO 的转录调节因子
了解其对晚期基因的抑制如何在晚期解除,以允许这些基因
来表达。我们假设 EUO 以依赖氧化还原的方式转化
从二聚体变成单体,然后通过蛋白水解作用降解。在目标 2 中,我们将
研究另一个称为 RsbW 的调节器,我们认为它是信号传导通路的一部分
σ28 RNA 聚合酶控制晚期基因子集的转录
对葡萄糖可用性的反应。目标 3 将使用共焦显微镜来检查这些
单个感染者中个体 RB 和 EB 的晚期基因调控机制
细胞。我们将研究晚期基因表达的调节因子是否也控制 RB-
到 EB 转换以及为什么这个关键转换步骤异步发生。这些
研究有可能带来治疗衣原体的新治疗策略
通过中断这一关键的转化步骤并防止产生感染
传染性细菌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ming Tan其他文献
Ming Tan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ming Tan', 18)}}的其他基金
A Nanoparticle-Based Multivalent Rotavirus Vaccine
基于纳米颗粒的多价轮状病毒疫苗
- 批准号:
10206373 - 财政年份:2020
- 资助金额:
$ 44.99万 - 项目类别:
Three-dimensional analysis and modeling of the Chlamydia developmental cycle
衣原体发育周期的三维分析和建模
- 批准号:
9207413 - 财政年份:2016
- 资助金额:
$ 44.99万 - 项目类别:
Three-dimensional analysis and modeling of the Chlamydia developmental cycle
衣原体发育周期的三维分析和建模
- 批准号:
9035928 - 财政年份:2016
- 资助金额:
$ 44.99万 - 项目类别:
Glucose metabolism and ErbB2-mediated cancer progression
葡萄糖代谢和 ErbB2 介导的癌症进展
- 批准号:
8233299 - 财政年份:2011
- 资助金额:
$ 44.99万 - 项目类别:
Norovirus P Particle, A Multifunctional Platform For Vaccine Development
诺如病毒粒子,疫苗开发的多功能平台
- 批准号:
8264954 - 财政年份:2011
- 资助金额:
$ 44.99万 - 项目类别:
Norovirus P Particle, A Multifunctional Platform For Vaccine Development
诺如病毒粒子,疫苗开发的多功能平台
- 批准号:
8190929 - 财政年份:2011
- 资助金额:
$ 44.99万 - 项目类别:
Glucose metabolism and ErbB2-mediated cancer progression
葡萄糖代谢和 ErbB2 介导的癌症进展
- 批准号:
9059029 - 财政年份:2011
- 资助金额:
$ 44.99万 - 项目类别:
Glucose metabolism and ErbB2-mediated cancer progression
葡萄糖代谢和 ErbB2 介导的癌症进展
- 批准号:
8448286 - 财政年份:2011
- 资助金额:
$ 44.99万 - 项目类别:
Glucose metabolism and ErbB2-mediated cancer progression
葡萄糖代谢和 ErbB2 介导的癌症进展
- 批准号:
8616726 - 财政年份:2011
- 资助金额:
$ 44.99万 - 项目类别:
Glucose metabolism and ErbB2-mediated cancer progression
葡萄糖代谢和 ErbB2 介导的癌症进展
- 批准号:
8041801 - 财政年份:2011
- 资助金额:
$ 44.99万 - 项目类别:
相似海外基金
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 44.99万 - 项目类别:
Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
- 批准号:
DP230102150 - 财政年份:2023
- 资助金额:
$ 44.99万 - 项目类别:
Discovery Projects
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
- 批准号:
468567 - 财政年份:2022
- 资助金额:
$ 44.99万 - 项目类别:
Operating Grants
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 44.99万 - 项目类别:
Australian Laureate Fellowships
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10708102 - 财政年份:2022
- 资助金额:
$ 44.99万 - 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10587015 - 财政年份:2022
- 资助金额:
$ 44.99万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10581945 - 财政年份:2021
- 资助金额:
$ 44.99万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10358855 - 财政年份:2021
- 资助金额:
$ 44.99万 - 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
- 批准号:
2599490 - 财政年份:2021
- 资助金额:
$ 44.99万 - 项目类别:
Studentship














{{item.name}}会员




